Antengene Future Growth
Future criteria checks 2/6
Antengene is forecast to grow earnings and revenue by 16.3% and 68.6% per annum respectively. EPS is expected to grow by 18.9% per annum. Return on equity is forecast to be -62.4% in 3 years.
Key information
16.3%
Earnings growth rate
18.9%
EPS growth rate
Pharmaceuticals earnings growth | 12.9% |
Revenue growth rate | 66.1% |
Future return on equity | -62.4% |
Analyst coverage | Low |
Last updated | 26 Aug 2024 |
Recent future growth updates
Recent updates
Revenues Tell The Story For Antengene Corporation Limited (HKG:6996)
Jan 09The Price Is Right For Antengene Corporation Limited (HKG:6996) Even After Diving 26%
Sep 20Antengene Corporation Limited (HKG:6996) Analysts Just Slashed This Year's Estimates
Apr 03We're Not Very Worried About Antengene's (HKG:6996) Cash Burn Rate
Feb 19Companies Like Antengene (HKG:6996) Are In A Position To Invest In Growth
Nov 05We Think Antengene (HKG:6996) Can Afford To Drive Business Growth
Jun 28We're Hopeful That Antengene (HKG:6996) Will Use Its Cash Wisely
Mar 08We're Hopeful That Antengene (HKG:6996) Will Use Its Cash Wisely
Nov 18Companies Like Antengene (HKG:6996) Are In A Position To Invest In Growth
Aug 17Companies Like Antengene (HKG:6996) Are In A Position To Invest In Growth
Apr 29What Type Of Shareholders Own The Most Number of Antengene Corporation Limited (HKG:6996) Shares?
Feb 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 405 | -344 | N/A | N/A | 2 |
12/31/2025 | 284 | -351 | N/A | N/A | 2 |
12/31/2024 | 118 | -336 | N/A | N/A | 2 |
6/30/2024 | 56 | -530 | N/A | N/A | N/A |
3/31/2024 | 62 | -555 | N/A | N/A | N/A |
12/31/2023 | 67 | -581 | -779 | -666 | N/A |
9/30/2023 | 123 | -628 | -869 | -743 | N/A |
6/30/2023 | 178 | -676 | -958 | -820 | N/A |
3/31/2023 | 169 | -639 | -814 | -696 | N/A |
12/31/2022 | 160 | -601 | -670 | -572 | N/A |
9/30/2022 | 121 | -584 | -652 | -589 | N/A |
6/30/2022 | 83 | -567 | -635 | -605 | N/A |
3/31/2022 | 56 | -611 | -610 | -581 | N/A |
12/31/2021 | 29 | -656 | -585 | -558 | N/A |
9/30/2021 | 14 | -1,640 | -515 | -468 | N/A |
6/30/2021 | -2 | -2,624 | -446 | -378 | N/A |
3/31/2021 | -1 | -2,777 | -403 | -343 | N/A |
12/31/2020 | N/A | -2,929 | -359 | -307 | N/A |
9/30/2020 | 4 | -1,842 | -294 | -267 | N/A |
6/30/2020 | 8 | -755 | -230 | -228 | N/A |
3/31/2020 | 10 | -539 | -176 | -175 | N/A |
12/31/2019 | 11 | -324 | -122 | -121 | N/A |
12/31/2018 | 7 | -146 | -114 | -113 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6996 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 6996 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 6996 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 6996's revenue (68.6% per year) is forecast to grow faster than the Hong Kong market (7.4% per year).
High Growth Revenue: 6996's revenue (68.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6996 is forecast to be unprofitable in 3 years.